MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 289 filers reported holding MYRIAD GENETICS INC in Q3 2018. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $596,000 | -41.5% | 21,885 | -38.5% | 0.06% | -44.0% |
| Q3 2019 | $1,018,000 | -46.4% | 35,567 | -47.9% | 0.10% | -48.2% |
| Q2 2019 | $1,898,000 | -16.3% | 68,323 | -0.0% | 0.19% | +13.5% |
| Q1 2019 | $2,268,000 | -16.6% | 68,324 | -26.9% | 0.17% | -19.0% |
| Q4 2018 | $2,718,000 | -23.3% | 93,502 | +21.3% | 0.21% | +15.4% |
| Q3 2018 | $3,545,000 | – | 77,060 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tieton Capital Management, LLC | 122,428 | $3,618,000 | 3.32% |
| Sensato Investors LLC | 553,505 | $16,356,000 | 2.54% |
| Camber Capital Management LP | 1,500,000 | $44,325,000 | 2.18% |
| S&T BANK/PA | 387,084 | $11,439,000 | 2.04% |
| Taylor Frigon Capital Management LLC | 46,989 | $1,389,000 | 1.08% |
| AIMZ Investment Advisors, LLC | 43,785 | $1,294,000 | 0.94% |
| Matarin Capital Management, LLC | 398,828 | $11,785,367,000 | 0.88% |
| Summit Street Capital Management, LLC | 30,097 | $889,000 | 0.88% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,321,171 | $39,041,000 | 0.77% |
| Millrace Asset Group, Inc. | 45,544 | $1,346,000 | 0.65% |